๐
๐๐ ๐๐ฅ๐๐๐ซ๐ฌ ๐๐๐ฎ๐๐๐ญ ๐๐๐๐๐จ๐ง ๐๐จ๐ซ ๐๐จ๐ง๐ข๐ง๐ฏ๐๐ฌ๐ข๐ฏ๐ ๐๐๐ญ๐ข๐ง๐๐ฅ ๐๐ฆ๐๐ ๐ข๐ง๐
๐ OcuSciences has received FDA clearance for the OcuMet Beacon, a noninvasive imaging device that assesses retinal health without dyes, injections, or direct eye contact. Using autofluorescence (AF) and infrared (IR) signals, the Beacon offers a fast, patient-friendly alternative for detecting retinal disease.
๐จโโ๏ธ Backed by peer-reviewed studies and set to be featured at ARVO 2025, the OcuMet Beacon is now ready for clinical use across the U.S.โmarking a major step forward in early, comfortable retinal diagnostics.